Can the FDA Keep Pace with CRISPR? Regulating Genome Tech in an Anti-Expert Era

How do we regulate world-altering tech like gene editing in an era that distrusts experts?

Authors

Institutions

Publication Details

Published
2025-01-01
DOI
https://doi.org/10.64240/7506e50d5e
Primary Topic
CRISPR and Genetic Engineering
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Can the FDA Keep Pace with CRISPR? Regulating Genome Tech in an Anti-Expert Era

Anne‐Marie Keller
1 links
CRISPR and Genetic Engineering
article

Can the FDA Keep Pace with CRISPR? Regulating Genome Tech in an Anti-Expert Era

Anne‐Marie Keller
article en

Abstract

How do we regulate world-altering tech like gene editing in an era that distrusts experts?

CI2 (CZ)
Openalex Percentile: Top 80%
CRISPR and Genetic Engineering
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Can the FDA Keep Pace with CRISPR? Regulating Genome Tech in an Anti-Expert Era — Anne‐Marie Keller · (2025) | TGRS Research Map | TGRS